Beth Sherrill

1.6k total citations
38 papers, 1.2k citations indexed

About

Beth Sherrill is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Beth Sherrill has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 7 papers in Economics and Econometrics. Recurrent topics in Beth Sherrill's work include Cancer Treatment and Pharmacology (11 papers), Advanced Breast Cancer Therapies (10 papers) and HER2/EGFR in Cancer Research (9 papers). Beth Sherrill is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), Advanced Breast Cancer Therapies (10 papers) and HER2/EGFR in Cancer Research (9 papers). Beth Sherrill collaborates with scholars based in United States, United Kingdom and France. Beth Sherrill's co-authors include Alicia Gilsenan, Xiaolei Zhou, F Coste, Robert West, James Nonnemaker, Yun Wu, Elizabeth Andrews, Kirk Midkiff, Mayur M. Amonkar and Daniel N. Masica and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Beth Sherrill

37 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beth Sherrill United States	17	350	332	160	153	151	38	1.2k
Bettina F. Drake United States	19	422 1.2×	153 0.5×	265 1.7×	58 0.4×	87 0.6×	70	1.3k
Enrico De Nigris United Kingdom	16	133 0.4×	172 0.5×	72 0.5×	138 0.9×	78 0.5×	54	1.2k
Linda Sarna United States	17	388 1.1×	387 1.2×	229 1.4×	49 0.3×	69 0.5×	33	1.3k
Soo Hyun Kim South Korea	23	979 2.8×	126 0.4×	267 1.7×	83 0.5×	70 0.5×	72	1.7k
Anuja Roy United States	11	210 0.6×	78 0.2×	126 0.8×	28 0.2×	112 0.7×	41	2.2k
Hema N. Viswanathan United States	23	350 1.0×	147 0.4×	130 0.8×	16 0.1×	79 0.5×	71	1.7k
Karen Gold United States	20	710 2.0×	428 1.3×	179 1.1×	132 0.9×	71 0.5×	37	2.0k
Jorma Komulainen Finland	22	190 0.5×	101 0.3×	298 1.9×	18 0.1×	200 1.3×	58	1.8k
Andrew Matthew Canada	21	643 1.8×	153 0.5×	132 0.8×	46 0.3×	43 0.3×	89	1.3k
Annette de Thurah Denmark	24	193 0.6×	58 0.2×	209 1.3×	33 0.2×	67 0.4×	99	1.8k

Countries citing papers authored by Beth Sherrill

Since Specialization

Citations

This map shows the geographic impact of Beth Sherrill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Sherrill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Sherrill more than expected).

Fields of papers citing papers by Beth Sherrill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth Sherrill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Sherrill. The network helps show where Beth Sherrill may publish in the future.

Co-authorship network of co-authors of Beth Sherrill

This figure shows the co-authorship network connecting the top 25 collaborators of Beth Sherrill. A scholar is included among the top collaborators of Beth Sherrill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth Sherrill. Beth Sherrill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sherrill, Beth, M. Fernandez, Jianmin Wang, et al.. (2015). NETWORK META-ANALYSIS OF RELATIVE EFFICACY AND SAFETY OF EDOXABAN VERSUS OTHER NOVEL ORAL ANTICOAGULANTS (NOACS) AMONG ATRIAL FIBRILLATION PATIENTS WITH CHADS2 SCORE ≥ 2. Journal of the American College of Cardiology. 65(10). A346–A346. 2 indexed citations

Trask, Peter C., Jianmin Wang, Robert Olivares, et al.. (2014). Randomized Controlled Trials in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma & Leukemia. 15(4). 199–207. 1 indexed citations

Odom, Dawn, et al.. (2014). Practical issues when conducting network meta-analyses with a limited number of studies. Value in Health. 17(3). A205–A205. 1 indexed citations

Sherrill, Beth, et al.. (2013). Q-TWiST analysis comparing ipilimumab/dacarbazine vs placebo/dacarbazine for patients with stage III/IV melanoma. British Journal of Cancer. 109(1). 8–13. 26 indexed citations

Andrews, Elizabeth, Alicia Gilsenan, Kirk Midkiff, et al.. (2012). The US postmarketing surveillance study of adult osteosarcoma and teriparatide: Study design and findings from the first 7 years. Journal of Bone and Mineral Research. 27(12). 2429–2437. 194 indexed citations

Chirila, Costel, Dawn Odom, Giovanna Devercelli, et al.. (2011). Meta-analysis of the association between progression-free survival and overall survival in metastatic colorectal cancer. International Journal of Colorectal Disease. 27(5). 623–634. 25 indexed citations

Zhao, Zhongyun, et al.. (2011). A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients with wild-type KRAS metastatic colorectal cancer. British Journal of Cancer. 104(12). 1848–1853. 20 indexed citations

Zhao, Zhongyun, et al.. (2011). PCN86 A Q-TWIST ANALYSIS COMPARING PANITUMUMAB PLUS BEST SUPPORTIVE CARE (BSC) WITH BSC ALONE IN PATIENTS WITH WILD-TYPE KRAS METASTATIC COLORECTAL CANCER. Value in Health. 14(3). A170–A170. 2 indexed citations

Sherrill, Beth, Michael T. Halpern, Shahnaz Khan, Jie Zhang, & Sumeet Panjabi. (2011). Single-Pill vs Free-Equivalent Combination Therapies for Hypertension: A Meta-Analysis of Health Care Costs and Adherence. Journal of Clinical Hypertension. 13(12). 898–909. 122 indexed citations

10.

Sherrill, Beth, Angelo Di Leo, Mayur M. Amonkar, et al.. (2010). Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer. Current Medical Research and Opinion. 26(4). 767–775. 12 indexed citations

11.

Wolf, Anne, Beth Sherrill, Xiaolei Zhou, et al.. (2010). Impact of Waist Circumference Difference on Health-Care Cost among Overweight and Obese Subjects: The PROCEED Cohort. Value in Health. 13(4). 402–410. 18 indexed citations

12.

Glück, Stefan, et al.. (2009). Relationship between survival and estrogen receptor (ER) status in pts with metastatic breast cancer (MBC) treated with capecitabine (C) and docetaxel (D): An exploratory data analysis. Journal of Clinical Oncology. 27(15_suppl). 1024–1024. 6 indexed citations

13.

Sherrill, Beth, et al.. (2008). Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer. British Journal of Cancer. 99(5). 711–715. 33 indexed citations

14.

Wolf, Alexander M., Nick Finer, Amanda A. Allshouse, et al.. (2008). PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sample*. Diabetes Obesity and Metabolism. 10(12). 1248–1260. 16 indexed citations

15.

Sherrill, Beth, Mayur M. Amonkar, Yun Wu, et al.. (2008). Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer. British Journal of Cancer. 99(10). 1572–1578. 62 indexed citations

16.

Allen, Richard P., et al.. (2006). Predictors of health-related quality of life in sufferers with restless legs syndrome: A multi-national study. Sleep Medicine. 8(1). 73–83. 42 indexed citations

17.

Tennis, Patricia, Beth Sherrill, Carlos Fernández‐Peña, & Chantal Dolan. (2005). Cancer risk in asthmatic populations. Annals of Allergy Asthma & Immunology. 95(4). 354–360. 6 indexed citations

18.

Irish, William, Beth Sherrill, Bernard F. Cole, et al.. (2005). Quality-adjusted survival in a crossover trial of letrozole versus tamoxifen in postmenopausal women with advanced breast cancer. Annals of Oncology. 16(9). 1458–1462. 18 indexed citations

19.

Raffanti, Stephen, Jennifer S Fusco, Beth Sherrill, et al.. (2004). Effect of Persistent Moderate Viremia on Disease Progression During HIV Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 37(1). 1147–1154. 43 indexed citations

20.

Irish, William, Beth Sherrill, Daniel C. Brennan, Jeffrey A. Lowell, & Mark A. Schnitzler. (2003). Three-year posttransplant graft survival in renal-transplant patients with graft function at 6 months receiving tacrolimus or cyclosporine microemulsion within a triple-drug regimen. Transplantation. 76(12). 1686–1690. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact